These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36677641)

  • 21. Physico-chemical properties of aluminum adjuvants in vaccines: Implications for toxicological evaluation.
    Badran G; Angrand L; Masson JD; Crépeaux G; David MO
    Vaccine; 2022 Aug; 40(33):4881-4888. PubMed ID: 35810062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic Reprogramming of Macrophages upon In Vitro Incubation with Aluminum-Based Adjuvant.
    Danielsson R; Ferey N; Mile I; Eriksson H
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Formulation and Suspension Properties on Redispersion of Aluminum-Adjuvanted Vaccines.
    Langford A; Horwitz T; Adu-Gyamfi E; Wiley C; Holding E; Zimmermann D; Ignatius AA; Ohtake S
    J Pharm Sci; 2020 Apr; 109(4):1460-1466. PubMed ID: 31930978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants.
    Jendrek S; Little SF; Hem S; Mitra G; Giardina S
    Vaccine; 2003 Jun; 21(21-22):3011-8. PubMed ID: 12798645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between protein adsorptive capacity and the X-ray diffraction pattern of aluminium hydroxide adjuvants.
    Masood H; White JL; Hem SL
    Vaccine; 1994 Feb; 12(2):187-9. PubMed ID: 8147102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response.
    Hansen B; Sokolovska A; HogenEsch H; Hem SL
    Vaccine; 2007 Sep; 25(36):6618-24. PubMed ID: 17681647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring the surface area of aluminum hydroxide adjuvant.
    Johnston CT; Wang SL; Hem SL
    J Pharm Sci; 2002 Jul; 91(7):1702-6. PubMed ID: 12115832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production.
    Iyer S; HogenEsch H; Hem SL
    Vaccine; 2003 Mar; 21(11-12):1219-23. PubMed ID: 12559801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins.
    Iyer S; HogenEsch H; Hem SL
    Pharm Dev Technol; 2003; 8(1):81-6. PubMed ID: 12665200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slow CCL2-dependent translocation of biopersistent particles from muscle to brain.
    Khan Z; Combadière C; Authier FJ; Itier V; Lux F; Exley C; Mahrouf-Yorgov M; Decrouy X; Moretto P; Tillement O; Gherardi RK; Cadusseau J
    BMC Med; 2013 Apr; 11():99. PubMed ID: 23557144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant.
    DePaz RA; Henderson I; Advant SJ
    Vaccine; 2005 Jul; 23(31):4029-35. PubMed ID: 15963360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.
    Beck Z; Torres OB; Matyas GR; Lanar DE; Alving CR
    J Control Release; 2018 Apr; 275():12-19. PubMed ID: 29432824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering the hydroxyl content on aluminum oxyhydroxide nanorod for elucidating the antigen adsorption behavior.
    Yu G; Liang Z; Yu Z; Li M; Yang W; Zhang Y; Zhao Y; Yang C; Xue C; Shi L; Sun B
    NPJ Vaccines; 2022 Jun; 7(1):62. PubMed ID: 35739192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants.
    al-Shakhshir R; Regnier F; White JL; Hem SL
    Vaccine; 1994 Apr; 12(5):472-4. PubMed ID: 8023556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles.
    Ruwona TB; Xu H; Li X; Taylor AN; Shi YC; Cui Z
    Vaccine; 2016 Jun; 34(27):3059-3067. PubMed ID: 27155490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biopersistence and systemic distribution of intramuscularly injected particles: what impact on long-term tolerability of alum adjuvants?].
    Gherardi RK; Cadusseau J; Authier FJ
    Bull Acad Natl Med; 2014 Jan; 198(1):37-48; discussion 49-53. PubMed ID: 26259285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.
    Iyer S; Robinett RS; HogenEsch H; Hem SL
    Vaccine; 2004 Mar; 22(11-12):1475-9. PubMed ID: 15063571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystalline and Amorphous Preparation of Aluminum Hydroxide Nanoparticles Enhances Protective Antigen Domain 4 Specific Immunogenicity and Provides Protection Against Anthrax.
    Gogoi H; Mani R; Aggarwal S; Malik A; Munde M; Bhatnagar R
    Int J Nanomedicine; 2020; 15():239-252. PubMed ID: 32021177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of Human Monocytes by Colloidal Aluminum Salts.
    Vrieling H; Kooijman S; de Ridder JW; Thies-Weesie DME; Soema PC; Jiskoot W; van Riet E; Heck AJR; Philipse AP; Kersten GFA; Meiring HD; Pennings JL; Metz B
    J Pharm Sci; 2020 Jan; 109(1):750-760. PubMed ID: 31449816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of aluminium-containing adjuvants.
    White JL; Hem SL
    Dev Biol (Basel); 2000; 103():217-28. PubMed ID: 11214239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.